Polymorphisms in lysosome autophagic genes are associated with poor outcomes in ccRCC [50], and mutations in SETD2, a frequent molecular feature of ccRCC, suppress autophagy regulation [51]. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.